Elite Pharmaceuticals, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Elite Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2013-12-31 was $158.33K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2013-12-31 | $158.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 |